Naphthalimides and Azonafides as Promising Anti-Cancer Agents
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1192-1213
Author(s):
Laurent Ingrassia, Florence Lefranc, Robert Kiss and Tatjana Mijatovic
Mitochondrial Respiratory Complex I: Structure, Function and Implication in Human Diseases
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1266-1277
Author(s):
Lokendra K. Sharma, Jianxin Lu and Yidong Bai
Synthesis of Coumarin linked Naphthalimide Conjugates as Potential Anticancer and Antimicrobial Agents
Journal:
Letters in Drug Design & Discovery
Volume:
6
Page:
201-209
Author(s):
Ahmed Kamal, S. F. Adil, Jaki R. Tamboli, B. Siddardha and U. S.N. Murthy
Editorial [Hot Topic: Drug Targets in Viral Infections (Guest Editor: Jean-Marc Sabatier)]
Journal:
Infectious Disorders - Drug Targets
Volume:
9
Page:
100-100
Author(s):
Jean-Marc Sabatier
PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
916-930
Author(s):
Peng Wu, Tao Liu and Yongzhou Hu
The Novel RARβ Isoform (β 5) is a Potential Target of Retinoids in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
142-147
Author(s):
Konstantin Christov
Nitric Oxide: Cancer Target or Anticancer Agent?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
214-236
Author(s):
Simone Mocellin
Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
957-965
Author(s):
Philip S. Murphy and Mats Bergstrom
Cancer Drug Development Using Glucose Metabolism Radiopharmaceuticals
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
983-987
Author(s):
Y. Y. Sun and Y. Chen
Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
758-776
Author(s):
P. Sapra Sharma, R. Sharma and T. Tyagi